Join to View Full Profile
2160 S 1st Ave# MaguireMaywood, IL 60153
Phone+1 708-216-2729
Dr. Solanki is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Chicago/University of Illinois College of Medicine at ChicagoResidency, Radiation Oncology, 2010 - 2014
Maimonides Medical CenterInternship, Transitional Year, 2009 - 2010
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 2009
Certifications & Licensure
IL State Medical License 2014 - 2026
American Board of Radiology Radiation Oncology
Clinical Trials
- Focal Salvage HDR Brachytherapy for Locally Recurrent Prostate Cancer in Patients Treated With Prior Radiotherapy Start of enrollment: 2017 Aug 28
- BEACON: HDR Brachytherapy, EBRT and STAD for the Treatment of Local and Pelvic Recurrence of Prostate Cancer After Radiation Therapy Start of enrollment: 2018 May 29
- A Study of Chemotherapy and Radiation Therapy Compared to Chemotherapy and Radiation Therapy Plus MEDI4736 (Durvalumab) Immunotherapy for Bladder Cancer Which Has Spread to the Lymph Nodes, INSPIRE Trial Start of enrollment: 2021 Mar 17
- Join now to see all
Publications & Presentations
PubMed
- The Importance of Multi-parametric MRI, PET/CT, and Biopsy for Identifying and Delineating the Extent of Intraprostatic Radiorecurrent Prostate Cancer: A Secondary Ana...Bhanu Prasad Venkatesulu, William Adams, Rebecca Joel, Dylan Ross, Ryan Yoo
International Journal of Radiation Oncology, Biology, Physics. 2025-03-06 - Leveraging Radiotherapy Data for Precision Oncology: Veterans Affairs Granular Radiotherapy Information Database.Evangelia Katsoulakis, Cecelia J Madison, Rishabh Kapoor, Ryan A Melson, Anthony Gao
JCO Clinical Cancer Informatics. 2025-02-01 - ACR Appropriateness Criteria® Pretreatment Staging of Urothelial Cancer: 2024 Update., Samantha J Barker, Esra Soylu, Brian C Allen, Moises Auron
Journal of the American College of Radiology. 2024-11-01
Authored Content
- Perspectives from Council of Affiliated Regional Radiation Oncology SocietiesJune 2019
- Perspectives from Council of Affiliated Regional Radiation Oncology SocietiesJune 2019
Press Mentions
Open Clinical Trials for Patients with Prostate CancerMarch 10th, 2025- 1 in 4 Cancer Radiotherapy Plans Change After Peer ReviewJanuary 23rd, 2025
- ‘STARPORT’ Trial Probes New Approach for Aggressive Prostate CancerAugust 16th, 2021
- Join now to see all
Grant Support
- Veterans Affairs seamless phase II/III randomized trial of STAndard systemic theRapy with or without PET-directed local therapy for OligoRecurrenT prostate cancer (VA STARPORT)EDWARD HINES JR VA HOSPITAL2021–2026
- Veterans Affairs seamless phase II/III randomized trial of STAndard systemic theRapy with or without PET-directed local therapy for OligoRecurrenT prostate cancer (VA STARPORT)Veterans Affairs Office of Research and Development2021–2026
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
